These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 20415612)
1. Use of metformin to control clozapine-associated weight gain in an adolescent with schizoaffective disorder. Weaver LA; De León DD; Borgmann-Winter K; Coffey BJ J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):153-7. PubMed ID: 20415612 [No Abstract] [Full Text] [Related]
2. Gaining: pediatric patients and use of atypical antipsychotics. Towbin KE Am J Psychiatry; 2006 Dec; 163(12):2034-6. PubMed ID: 17151148 [No Abstract] [Full Text] [Related]
3. Efficacy of metformin and topiramate in prevention and treatment of second-generation antipsychotic-induced weight gain. Ellinger LK; Ipema HJ; Stachnik JM Ann Pharmacother; 2010 Apr; 44(4):668-79. PubMed ID: 20233913 [TBL] [Abstract][Full Text] [Related]
4. CoMET: a protocol for a randomised controlled trial of co-commencement of METformin as an adjunctive treatment to attenuate weight gain and metabolic syndrome in patients with schizophrenia newly commenced on clozapine. Siskind D; Friend N; Russell A; McGrath JJ; Lim C; Patterson S; Flaws D; Stedman T; Moudgil V; Sardinha S; Suetani S; Kisely S; Winckel K; Baker A BMJ Open; 2018 Mar; 8(3):e021000. PubMed ID: 29500217 [TBL] [Abstract][Full Text] [Related]
5. Clozapine: weight gain in a pair of monozygotic twins concordant for schizophrenia and mild mental retardation. Wehmeier PM; Gebhardt S; Schmidtke J; Remschmidt H; Hebebrand J; Theisen FM Psychiatry Res; 2005 Feb; 133(2-3):273-6. PubMed ID: 15741002 [TBL] [Abstract][Full Text] [Related]
6. Metformin in an Adolescent with Significant Weight Gain. Salau M; Adam B; Coffey BJ J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):589-92. PubMed ID: 26375769 [No Abstract] [Full Text] [Related]
7. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study. de Silva VA; Dayabandara M; Wijesundara H; Henegama T; Gunewardena H; Suraweera C; Hanwella R J Psychopharmacol; 2015 Dec; 29(12):1255-61. PubMed ID: 26510448 [TBL] [Abstract][Full Text] [Related]
9. Choice of an antipsychotic. Med Lett Drugs Ther; 2003 Dec; 45(1172):102-4. PubMed ID: 14679353 [No Abstract] [Full Text] [Related]
10. Repeated occurrence of clozapine-induced myocarditis in a patient with schizoaffective disorder and comorbid Parkinson's disease. Masopust J; Urban A; Valis M; Malý R; Tůma I; Hosák L Neuro Endocrinol Lett; 2009 Mar; 30(1):19-21. PubMed ID: 19300384 [TBL] [Abstract][Full Text] [Related]
11. Metformin as a Possible Intervention for Cardiometabolic Risks in Pediatric Subjects Exposed to Antipsychotic Drugs. Andrade C J Clin Psychiatry; 2016 Oct; 77(10):1362-1364. PubMed ID: 27788311 [TBL] [Abstract][Full Text] [Related]
13. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review. Newall H; Myles N; Ward PB; Samaras K; Shiers D; Curtis J Int Clin Psychopharmacol; 2012 Mar; 27(2):69-75. PubMed ID: 21979790 [TBL] [Abstract][Full Text] [Related]
14. Pancreatitis associated with metformin used for management of clozapine-related weight gain. McFadden M; Gordon A; Leong G; Ward D; Scott JG Aust N Z J Psychiatry; 2016 Jul; 50(7):701-2. PubMed ID: 26883571 [No Abstract] [Full Text] [Related]
15. Metformin in prevention and treatment of antipsychotic induced weight gain: a systematic review and meta-analysis. de Silva VA; Suraweera C; Ratnatunga SS; Dayabandara M; Wanniarachchi N; Hanwella R BMC Psychiatry; 2016 Oct; 16(1):341. PubMed ID: 27716110 [TBL] [Abstract][Full Text] [Related]
16. Metformin for Clozapine Associated Obesity: A Systematic Review and Meta-Analysis. Siskind DJ; Leung J; Russell AW; Wysoczanski D; Kisely S PLoS One; 2016; 11(6):e0156208. PubMed ID: 27304831 [TBL] [Abstract][Full Text] [Related]
18. Metformin for treatment of antipsychotic-induced amenorrhea and weight gain in women with first-episode schizophrenia: a double-blind, randomized, placebo-controlled study. Wu RR; Jin H; Gao K; Twamley EW; Ou JJ; Shao P; Wang J; Guo XF; Davis JM; Chan PK; Zhao JP Am J Psychiatry; 2012 Aug; 169(8):813-21. PubMed ID: 22711171 [TBL] [Abstract][Full Text] [Related]